WWHealthcare · Medical Care FacilitiesThe 3 Wall Street analysts covering WW International, Inc. hold a median 12-month price target of $30 — +66.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 61 of 100 as at 5 Sept 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores WW International, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Issuance (98): The share count has been shrinking and the company is not leaning on new borrowing.
Growth (7): Sales and profits are flat, shrinking, or growing more slowly than they were.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on WW, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +66.5% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 15 Jan 2026 | Morgan Stanley | Maintains | Equal-Weight | $38 → $35 |
| 12 Aug 2025 | Morgan Stanley | Maintains | Equal-Weight | — |
| 8 July 2025 | LUCID CAPITAL MARKETS | Initiates | Buy | — |
| 10 Oct 2024 | Barclays | Maintains | Underweight | $0.75 |
| 2 Aug 2024 | Barclays | Maintains | Underweight | — |
| 2 Aug 2024 | Guggenheim | Maintains | Buy | — |
| 2 Aug 2024 | UBS | Maintains | Neutral | — |
| 3 May 2024 | DA Davidson | Maintains | Buy | — |
| 25 Apr 2024 | UBS | Maintains | Neutral | — |
| 18 Mar 2024 | Guggenheim | Reiterates | Buy | — |
| 14 Mar 2024 | DA Davidson | Maintains | Buy | — |
| 4 Mar 2024 | DA Davidson | Reiterates | Buy | — |
| 1 Mar 2024 | Barclays | Maintains | Underweight | — |
| 29 Feb 2024 | UBS | Maintains | Neutral | — |
| 1 Feb 2024 | Goldman Sachs | Maintains | Buy | — |
| 23 Jan 2024 | Goldman Sachs | Maintains | Buy | — |
| 20 Dec 2023 | Guggenheim | Initiates | Buy | — |
| 9 Oct 2023 | DA Davidson | Reiterates | Buy | — |
| 27 Sept 2023 | Craig-Hallum | Upgrade | Hold | — |
| 25 Sept 2023 | DA Davidson | Reiterates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. WW appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Sept 2026, WW International, Inc. returned −43.6% against +20.0% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 70% of US stocks
Cheaper than 90% of US stocks
Cheaper than 84% of US stocks
Cheaper than 53% of US stocks
Higher than 13% of US stocks
Higher than 2% of US stocks
Higher than 83% of US stocks
Higher than 61% of US stocks
Higher than 17% of US stocks
Higher than 27% of US stocks
Higher than 42% of US stocks
Higher than 76% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
WW International, Inc. has a market value of $180.2M and an enterprise value of $501.9M.
Revenue in the twelve months to 30 June 2026: $677.7M. The latest quarter shrank 14.2% year on year.
Net income over the same four quarters: −$100.0M, a −14.8% net margin.
Free cash flow in the twelve months to 30 June 2026: −$26.8M, after $23.1M of capital spending.
Trailing P/E: 1.6×; forward P/E: −125.7× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 3.90%, paying out 0% of earnings.
WW International, Inc. employs 3,500 people — $194K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own WW International, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
WW International, Inc. (Weight Watchers) announced it will participate in the Morgan Stanley Annual Global Healthcare Conference on Tuesday, September 15th. The company made the announcement on September 3, 2026.
Why it matters — Participation in a major investment conference gives WW an opportunity to present its business to healthcare-focused investors and analysts.
The article, sourced from 24/7 Wall Street, looks at what prediction markets indicate about three struggling brands, including WW International, that are fighting to survive. It examines the market's outlook on these companies' prospects.
Why it matters — The piece suggests WW is viewed as one of several struggling brands whose survival is uncertain, which is relevant to those tracking the company's outlook.
WW International, Inc. (WW) held its Q2 2026 earnings call, and the full transcript of that call was published on Seeking Alpha. The excerpt provides the headline and source but no details on the financial results discussed.
Why it matters — A WW watcher would care because the transcript offers direct access to management's commentary on the company's second-quarter results and outlook.
WW International reported second-quarter 2026 revenue of $162.3 million, down from $189.2 million in the prior year, while highlighting growth in its clinical and higher-value behavioral membership tiers and reaffirming its full-year financial outlook.
Why it matters — WW watchers would care because the report shows revenue declined year over year even as the company points to growth in higher-value membership segments and maintains its full-year guidance.
Weight Watchers (WW International) reported second-quarter 2026 results with total end-of-period subscribers of 2.5 million, including 197 thousand clinical subscribers (up 55.7% year-over-year) and 541 thousand Core+ subscribers (up 13.9%, a third consecutive quarter of sequential growth). Revenue reached $162.3 million, with clinical subscription revenue of $39.9 million (up 30.4% year-over-year), and the company reaffirmed its full-year 2026 financial guidance.
Why it matters — A WW watcher would care because the results show continued growth in higher-value clinical and Core+ subscriptions and reaffirmed guidance, indicating the company's transition efforts are progressing.
The 3 Wall Street analysts covering WW International, Inc. have a median 12-month price target of $30, with estimates ranging from $20 to $35. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 3 analysts covering WW International, Inc., 1 rate it a Buy, 2 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks WW International, Inc. 61 out of 100 across roughly 4,600 US stocks as at 5 Sept 2026. None of this is personal advice — it does not consider your circumstances.
As at 5 Sept 2026, WW International, Inc. ranks 61 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (98 of 100).
No one can know that. What the data says: the median 12-month target from 3 analysts implies +66.5% from the last close, and Ticker Nerd's factor model ranks WW International, Inc. 61 out of 100 as at 5 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering WW International, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for WW are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $20 to $35 over the next 12 months.
WW International, Inc. returned -43.6% over the 12 months to 4 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
WW International is a global wellness company offering science-backed weight management programs and services. Founded in 1963 and headquartered in New York, the company operates under the Weight Watchers brand, providing a comprehensive ecosystem designed to support sustainable weight loss and healthy lifestyle changes.
The most recent item we track (GlobeNewsWire, 3 Sept 2026): "Weight Watchers to Participate in Morgan Stanley Annual Global Healthcare Conference". WW International, Inc. (Weight Watchers) announced it will participate in the Morgan Stanley Annual Global Healthcare Conference on Tuesday, September 15th. The company made the announcement on September 3, 2026.
WW International is a global wellness company offering science-backed weight management programs and services. Founded in 1963 and headquartered in New York, the company operates under the Weight Watchers brand, providing a comprehensive ecosystem designed to support sustainable weight loss and healthy lifestyle changes. WW delivers its programs through multiple channels: digital platforms featuring mobile apps and online tools, in-person wellness workshops led by certified coaches, and virtual coaching services. The company's flagship myWW+ program utilizes the SmartPoints system, which quantifies foods based on nutritional content including carbohydrates, fat, and fiber. WW also operates a clinical division offering GLP-1 medication programs for eligible members, integrating pharmaceutical interventions with behavioral support. Beyond core subscription services, WW generates revenue through licensed branded food products, cookbooks, and merchandise. The company serves members across North America and international markets, positioning itself as a comprehensive weight health platform that combines behavioral techniques, nutritional guidance, clinical care, technology-enabled support, and community connection to help members achieve lasting results.
CEO Ms. Tara M. Comonte · 3,500 employees · United States · https://corporate.ww.com
